The owner of one of the three largest pharmacy middlemen in the United States last week filed ... against the three pharmacy ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

A recent study by researchers at Shandong University in China found that insulin resistance is linked to an increased risk of several diseases and early death in women. Insulin resistance occurs when ...

Eli Lilly (NYSE:LLY) on Thursday announced that its QWINT-1 and QWINT-3 Phase 3 clinical trials for once-weekly insulin efsitora alfa reached the primary endpoints against daily basal insulins ...

In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a ...

The U.S. Drug Enforcement Administration (DEA) has allowed an increase in Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The DEA greenlighted the spike in ...

The trial results come less than two months after the U.S. Food and Drug Administration rejected Novo Nordisk's application for approval of a once-weekly basal insulin for diabetes patients.

Bridging the gap: Inaugural year of dental assisting program begins in Minot Can Kamala Harris beat Donald Trump? Latest poll updates Jennifer Lopez, Rita Moreno, And More Latine Celebrities Who ...

The overall safety of insulin efsitora was similar to that of daily basal insulin therapies. Topline data were announced from 2 studies in the QWINT phase 3 clinical development program ...